Why the study?
Does modulating Id gene expression with tacrolimus alter right ventricular hemodynamics in a mouse model of HF-PH, and are ID gene variations associated with PH development in human heart failure?
Does modulating Id gene expression with tacrolimus alter right ventricular hemodynamics in a mouse model of HF-PH, and are ID gene variations associated with PH development in human heart failure?
Modulating Id gene expression using tacrolimus worsened right ventricular systolic pressure in a mouse model of HF-PH, while genetic variations in human ID genes showed suggestive but non-significant associations with reduced risk of PH development in heart failure.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in HF-PH models; leaves open translation of tacrolimus or Id induction to human outcomes.
Objective: genes associated with HF-PH. Design: Experimental study using an AKR/J mouse model of HF-PH and a genetic association study using the UK Biobank cohort. Setting: Laboratory animal study and population-based cohort study. Participants: AKR/J mice with HF-PH and participants with HF from the UK Biobank cohort. Interventions: Administration of tacrolimus (Id signaling inducer) in the mouse model. Main outcome measures: with PH development and mortality in participants with HF. Results: ) trended toward reduced risk of PH in HF and all-cause mortality in participants with HF-PH. Conclusion: are involved in HF-PH pathogenesis, but more research is needed to characterize their exact role.
No takes yet. Share an insight, caveat, or question.
Lteif et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: